A patient with acantholytic pustular purpuric eruption due to gefitinib successfully treated with systemic antibiotics

Chen, Kai-LungKai-LungChenYUNG-TSU CHOYang, Che-WenChe-WenYangYI-SHUAN SHEENJAU-YU LIAUCHIA-YU CHU2020-03-052020-03-0520161027-8117https://www.scopus.com/inward/record.uri?eid=2-s2.0-84957895075&doi=10.1016%2fj.dsi.2015.12.005&partnerID=40&md5=94b9a8057db3d0e34292530064277694https://scholars.lib.ntu.edu.tw/handle/123456789/470335en[SDGs]SDG3antihistaminic agent; cefazolin; chloramphenicol; corticosteroid; emollient agent; gefitinib; vasculotropin receptor; acantholysis; aged; case report; exon; gene deletion; human; human tissue; hypertension; Letter; leukocytosis; lymphocytic infiltration; male; non small cell lung cancer; papule; pruritus; purpuric rash; pustule; skin atrophy; skin biopsy; Staphylococcus aureus; Staphylococcus infection; tissue culture; very elderly; wound care; xerosisA patient with acantholytic pustular purpuric eruption due to gefitinib successfully treated with systemic antibioticsletter10.1016/j.dsi.2015.12.0052-s2.0-84957895075